Otsuka Precision Health, Inc. (OPH) and Amalgam Rx Announce the Digital Support Solution for Caregivers Supporting Patients with Alzheimer’s Disease 
Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences
HAMBURG / ACCESSWIRE / March 20, 2019 / Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the...
Budget 2019: Collaboration is Essential to Success of National Pharmacare
OTTAWA, ON / ACCESSWIRE / March 19, 2019 / Innovative Medicines Canada (IMC) welcomes the measures taken in Budget 2019...
Intellipharmaceutics Receives Nasdaq Listing Determination; To Begin Trading on the OTC Markets System
TORONTO, ON / ACCESSWIRE / March 19, 2019 / Intellipharmaceutics International Inc. (Nasdaq and TSX: IPCI) ("Intellipharmaceutics" or the "Company"),...
ReShape Lifesciences to Host Fourth Quarter and Full Year 2018 Conference Call on April 1, 2019
SAN CLEMENTE, CA / ACCESSWIRE / March 19, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Aytu BioScience Announces Two Recent Publications Highlighting Improved Efficacy and Patient Preference of Natesto Nasal Testosterone over Topical Gels
Natesto ''MY-T study'' - First Study to Demonstrate Improvement of Low T Symptoms in Men After Switching to Natesto from...
Schlomo Schmuel & Sunset Foot Clinic set to Relocate in Coming Months
The Sunset Foot Clinic - home of the famous Happy Foot Sad Foot spinning logo on Sunset Boulevard in Silver...
Nevada Facility Runs Test of New Processing System
VANCOUVER, BC / ACCESSWIRE / March 19, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Evotec And GARDP Announce New Partnership To Discover Novel Antibiotics
COLLABORATION EXPLORES OPPORTUNITIES TO SET UP ANTIBIOTIC DISCOVERY AND DEVELOPMENT PLATFORM AND ESTABLISH A JOINT PIPELINE OF NOVEL ANTIBIOTIC ASSETS...
Cerecor Reports Fourth Quarter and Full Year 2018 Results
-Significant Advancement in Pipeline and Regulatory Milestones-Meets Increased 2018 Revenue Guidance-Announces Net Revenue Guidance of $20-22 Million for 2019 ROCKVILLE,...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2019
DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2019 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB: PBSV),...
Champions Oncology Reports Quarterly Revenue of $6.4 Million
Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019 HACKENSACK, NJ / ACCESSWIRE / March 18,...
Holistic Medicine Practice In Brooklyn NY Announces New Website Launch
BROOKLYN, NY / ACCESSWIRE / March 18, 2019 / Dr. Kamau Kokayi with Healing Health Services in Brooklyn, New York,...
Sterna Biologicals Holds Scientific Advisory Board Meeting at 14th Congress of ECCO to Advance Phase IIb Clinical Development Program of SB012 in Ulcerative Colitis
- Meeting included international key opinion leaders - Input provided on SB012 development plan and phase IIb trial protocol MARBURG,...
Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update
TORONTO, ON / ACCESSWIRE / March 18, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) Announces that it has filed...
Ozop Surgical Corp Provides Corporate Update and Outlook for 2019
WEST PALM BEACH, FL / ACCESSWIRE / March 18, 2019 / Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium...
WNDM Medical Inc. Acquires Remaining 50% Interest in Cellerate, LLC from an Affiliate of The Catalyst Group, Inc; Elects Ron Nixon to its Board of Directors
FORT WORTH, TX / ACCESSWIRE / March 18, 2019 / WNDM Medical Inc. (OTCQB: WNDM) Based in Fort Worth, Texas,...
Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute
Excellent Initial Flow Rates Achieved with CoreoGrafts for Bypasses Completed in Two Test Subjects IRVINE, CA / ACCESSWIRE / March...
Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) Announces Entry into the CBD Market
SACRAMENTO, CA / ACCESSWIRE / March 18, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today its immediate entry...
AXT107 Restores Healthy, Non-Leaky Vasculature in the Eye by Inhibiting VEGFR2 and Activating Tie2, the Two Clinically Validated Pathways in Diseases of the Retina
AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor...
Covenant Care California, LLC Notice of Data Privacy Incident
ALISO VIEJO, Calif., March 15, 2019 /PRNewswire/ -- Covenant Care California, LLC ("Covenant Care"), provides supportive and resource services to...